The Relationship Between Citicoline Administration and the National Institute of Health Stroke Scale in Hemorrhagic Stroke Patients at Dr. Regional General Hospital Chasbullah Abdulmadjid Bekasi City in 2022

Background: Hemorrhagic stroke is a focal or generalized neurological deficit that occurs suddenly within seconds or hours caused by a ruptured blood vessel.Hemorrhagic stroke can be divided into Intracerebral Hemorrhage (ICH)and Subarachnoid Hemorrhage (SAH). The prevalence of stroke in Indonesia, according to Riskesdas, in 2018 reached 10.9%; the highest cases occurred at the age of ≥55 years and were dominated by men. Treatment of hemorrhagic stroke can use citicoline as a neuroprotectant to repair brain cell membranes. One of the tools that can be used if there is a neurological deficit is the National Institute of Health Stroke Scale (NIHSS), which is useful for assessing the state of improvementof post-stroke patients. Purpose: To determine the relationship between the administration of citicoline and the NIHSS of hemorrhagic stroke patients. Methods: Descriptive analytics with a cross- sectional design using medical record data from the Regional General Hospital dr. Chasbullah Abdulmadjid Bekasi City had 95 patients based on the inclusion criteria. Results: The data from this study were processed using the Chi-Square test, which showed a significant relationship between citicoline administration and the NIHSS in hemorrhagic stroke patients with p-value = 0.017 (p